BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Bone Therapeutics is Breaking New Ground in Bone Remodeling

  Complicated bone fractures take a long while to heal. Bone Therapeutics S.A. is developing a cell therapy product that speeds bone regeneration and just may solve that problem.

  May 8, 2022

   · 

  4 min read

   · 

  Gail Dutton
• InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers

  InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug resistance for hard-to-treat solid tumors, announced that it had completed $15 million in Series B+ Financing.

  May 8, 2022

   · 

  4 min read
• JW Therapeutics to Present Latest Data of Carteyva® at 2022 ASCO Annual Meeting

  JW Therapeutics announced that it will present the latest clinical study data for Carteyva® via poster presentations and online publication at the 2022 American Society of Clinical Oncology Annual Meeting.

  May 8, 2022

   · 

  3 min read